Published in Gene Therapy Weekly, January 18th, 2007
The combined company will be named Intrexon Corporation and be headquartered in Blacksburg with supporting facilities in Norristown.
RheoGene has developed technology to manage gene expression, a key component of gene-based therapies. The suburban Philadelphia-based company specializes in gene-regulation systems designed to deliver precise genetic control for new medical applications including cellular and gene therapies, genomics and enhanced...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.